[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"shoulder-fractures\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:shoulder-fractures":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,9,0,[8,47,80,107,129,148,182,205,230],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":30,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100586828","zimmer-biomet-shoulder-arthroplasty-pmcf-study-100586828",false,"NCT06920459","Zimmer Biomet Shoulder Arthroplasty PMCF Study","Zimmer Biomet Shoulder Arthroplasty Long-term Post Market Clinical Follow-up Study","Inclusion Criteria:\n\n* Patient must be 20 years of age or older.\n* Patient must be anatomically and structurally suited to receive shoulder arthroplasty implants.\n* Patient is a candidate for shoulder arthroplasty due to one or more of the following:\n\nNon-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis.\n\nRheumatoid arthritis. Fractures of the proximal humerus, where other methods of treatment are deemed inadequate.\n\nDifficult clinical management problems, where other method of treatment may not be suitable or may be inadequate.\n\n* Patient must be able and willing to complete the protocol required follow-up.\n* Patient must be able and willing to sign the IRB\u002FEC approved informed consent.\n\nExclusion Criteria:\n\n* Patient is unwilling or unable to give consent or to comply with the follow-up program.\n* Patient has any condition which would in the judgement of the Investigator, place the patient at undue risk or interfere with the study.\n* Patient is known to be pregnant or breastfeeding.\n* Patient is a vulnerable subject (prisoner, mentally incompetent or unable to understand what participation to the study entails, a known alcohol or drug abuser, and\u002For anticipated to be non- compliant).\n* Patient is uncooperative or patient with neurologic disorders who is incapable or unwilling to follow directions.\n* Patient has any sign of infection affecting the shoulder joint or in its proximity which may spread to the implant site.\n* Patient has rapid joint destruction, marked bone loss, or bone resorption apparent on roentgenogram.\n* Patient has any neuromuscular disease compromising the affected limb that would render the procedure unjustifiable.\n* Patient presents with osteoporosis, which in the opinion of the Investigator, may limit the subject's ability to support total shoulder arthroplasty using the study device.\n* Patient has a metabolic disorder that may impair bone formation.\n* Patient has osteomalacia.","ALL","20 Years",{"count":19,"type":20},50,"ESTIMATED","OBSERVATIONAL","This is a multicenter, prospective, non-controlled post market surveillance study. The objectives of this study are to confirm the safety, performance, and clinical benefits of the Zimmer Biomet Shoulder Arthroplasty systems in primary anatomic shoulder arthroplasty and its instrumentation. Safety of the systems will be assessed by monitoring the frequency and incidence of adverse events. The performance and clinical benefits will be evaluated by assessment of the overall pain and functional performance, qualify of life, and radiographic parameters of all enrolled study subjects.",[24,25,26,27,28,29],"Shoulder Fractures","Shoulder Arthritis Osteoarthritis","Shoulder Injury","Shoulder Pain","Degenerative Joint Disease","Arthritis Shoulder",[31,32,33],"medical device","PMCF","Anatomic Total Shoulder Arthroplasty","RECRUITING","2026-06-05",{"date":37,"type":38},"2026-06-08","ACTUAL",{"date":40,"type":38},"2025-04-29",{"date":42,"type":20},"2037-06",{"name":44,"class":45},"Zimmer Biomet","INDUSTRY",2,{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":11,"sex":16,"minAge":55,"maxAge":56,"enrollmentInfo":57,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":59,"conditions":60,"keywords":62,"overallStatus":68,"whyStopped":4,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":79},"100634901","radiologist-integrated-finite-element-framework-for-acromial-stress-in-reverse-shoulder-arthroplasty-100634901","NCT07545707","Radiologist-Integrated Finite Element Framework for Acromial Stress in Reverse Shoulder Arthroplasty","From Clinical Grading to Mechanical Vulnerability: A Radiologist-Integrated Parametric Finite Element Study of Progressive Cuff Deficiency and Acromial Overload in Reverse Shoulder Arthroplasty","RIFA-RSA","Inclusion Criteria:\n\n* Adult patients (60-80 years) with cuff tear arthropathy (Hamada grade 3 or above, Walch glenoid B\u002FC) scheduled for primary unilateral reverse shoulder arthroplasty\n* Availability of preoperative high-resolution CT (voxel 1 mm or less) and 1.5T\u002F3T MRI\n* Written informed consent for prospective use of anonymised data\n\nExclusion Criteria:\n\n* Revision RSA or history of prior shoulder prosthetic complications\n* Uncorrectable imaging artefacts\n* Post-RSA follow-up shorter than 6 months","60 Years","80 Years",{"count":58,"type":20},13,"The current prospective single-center study is designed to examine an approach that utilizes both high-resolution CT and MRI scans, coupled with customized finite element modelling to analyze the stress placed on the acromion of patients who have undergone RSA surgery. The degree of rotator cuff deficiency will be assessed using Goutallier classification and quantified as Cuff Deficiency Index (CDI), which directly provides biomechanical information for calculating deltoid forces used in finite element analysis. Von Mises stresses will then be analyzed in anatomically defined acromial zones (Levy zones I-III).",[61,24],"Rotator Cuff Injuries",[63,64,65,66,67],"reverse shoulder arthroplasty","finite element analysis","acromial fracture","rotator cuff","biomechanics","NOT_YET_RECRUITING","2026-05-06",{"date":71,"type":38},"2026-05-11",{"date":73,"type":20},"2026-06-01",{"date":75,"type":20},"2027-03-05",{"name":77,"class":78},"University of Molise","OTHER",1,{"id":81,"slug":82,"hasResults":11,"nctId":83,"briefTitle":84,"officialTitle":85,"acronym":86,"eligibilityCriteria":87,"healthyVolunteers":11,"sex":16,"minAge":88,"maxAge":4,"enrollmentInfo":89,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":91,"conditions":92,"keywords":93,"overallStatus":68,"whyStopped":4,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":101,"completionDateStruct":103,"leadSponsor":105,"locationsCount":79},"100636310","clinical-decision-rule-for-excluding-shoulder-fractures-100636310","NCT07564024","Clinical Decision Rule for Excluding Shoulder Fractures","Development and External Validation of a Clinical Decision Rule for Excluding Shoulder Fractures: A Prospective Multicentre Diagnostic Accuracy and Cost-Effectiveness Study (SFER Study)","SFER","Inclusion Criteria:\n\n* Adult patients aged 18 years or older presenting with acute shoulder trauma within 7 days of injury will be eligible for inclusion\n\nExclusion Criteria:\n\n\\- Patients with polytrauma, previous shoulder surgery, open fractures, or inability to cooperate with clinical assessment will be excluded.","18 Years",{"count":90,"type":20},1216,"Many patients with shoulder injuries undergo X-rays even when fractures are unlikely, leading to unnecessary costs and delays in care. This study aims to develop a simple and reliable clinical tool to help healthcare providers determine when imaging is not required. By evaluating this tool in a large number of patients, we aim to improve patient care, reduce waiting times, and optimize the use of healthcare resources.",[24],[94,95,24,96,97],"Validation","Clinical Decision Rule","Diagnostic Accurac","and Cost-Effectiveness","2026-04-26",{"date":100,"type":38},"2026-05-04",{"date":102,"type":20},"2026-07-01",{"date":104,"type":20},"2026-12-01",{"name":106,"class":78},"Cairo University",{"id":108,"slug":109,"hasResults":11,"nctId":110,"briefTitle":111,"officialTitle":112,"acronym":4,"eligibilityCriteria":113,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":114,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":116,"conditions":117,"keywords":4,"overallStatus":68,"whyStopped":4,"lastUpdateSubmitDate":121,"lastUpdatePostDateStruct":122,"startDateStruct":124,"completionDateStruct":126,"leadSponsor":128,"locationsCount":79},"100625331","osseofit-stemless-shoulder-system-anatomic-100625331","NCT07421245","OsseoFit Stemless Shoulder System (Anatomic)","OsseoFit Stemless Shoulder System (Anatomic) Post-Market Clinical Follow-up Study","Inclusion Criteria:\n\n* Patient must be 20 years of age or older.\n* The patient must be anatomically and structurally suited, as evident by scapula and proximal humerus closure, to receive the implants.\n* Patient planned to receive OsseoFit™ anchor with uncemented fixation.\n* Patient planned to receive a Modular Alliance Glenoid with bone cement. The porous posts must be coated with Porous Plasma Spray (PPS) and may be inserted without bone cement.\n* Patient planned to receive shoulder arthroplasty due to osteoarthritis.\n* Patient must be able and willing to complete the protocol required follow-up schedule.\n* Patient must be able and willing to sign the IRB approved consent.\n\nExclusion Criteria:\n\n* Patient is unwilling or unable to give consent or to comply with the follow-up program.\n* Patient has any condition which would in the judgement of the Investigator, place the patient at undue risk or interfere with the study.\n* Patient is known to be pregnant or breastfeeding.\n* Patient is a vulnerable participant (prisoner, mentally incompetent or unable to understand what participation to the study entails, a known alcohol or drug abuser, and\u002For anticipated to be non-compliant).\n* Patient is uncooperative or patient with neurologic disorders who is incapable or unwilling to follow directions.\n* Patient has any neuromuscular disease compromising the affected limb.\n* Patient has any sign of infection affecting the shoulder joint or in its proximity which may spread to the implant site. This may include:\n\n  * Local\u002Fsystemic infection\n  * Sepsis\n  * Osteomyelitis\n* Patient presents with Osteomalacia.\n* Patient presents with a humeral bone fracture.\n* Patient presents with malunion or non-union of the tuberosities of the proximal humerus.\n* Patient has had a previous operative shoulder prosthesis (stem or stemless).\n* Patient has irreparable cuff tear.\n* Patient presents with inadequate humeral bone, which in the opinion of the Investigator, may lead to poor implant fixation. This may include but is not limited to:\n\n  * Osteoporosis\n  * Extensive Avascular Necrosis\n  * Rheumatoid Arthritis\n  * Metaphyseal bony defects (including large cysts)",{"count":115,"type":20},136,"The purpose of this clinical research protocol is to evaluate the safety, efficacy, and long-term outcomes of the OsseoFit Stemless Shoulder System (Anatomic) in patients with a primary diagnosis of osteoarthritis. The study aims to assess the intraoperative characteristics, postoperative complications, functional outcomes, and radiographic findings associated with the use of the stemless implant system. Ultimately, this research aims to improve patient outcomes, enhance surgical techniques, and inform clinical decision-making in the treatment of shoulder pathology.",[118,27,24,119,120],"Shoulder Injuries","Shoulder Arthritis","Shoulder Disease","2026-04-22",{"date":123,"type":38},"2026-04-23",{"date":125,"type":20},"2026-04",{"date":127,"type":20},"2036-01",{"name":44,"class":45},{"id":130,"slug":131,"hasResults":11,"nctId":132,"briefTitle":133,"officialTitle":134,"acronym":4,"eligibilityCriteria":135,"healthyVolunteers":11,"sex":16,"minAge":88,"maxAge":136,"enrollmentInfo":137,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":139,"conditions":140,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":121,"lastUpdatePostDateStruct":141,"startDateStruct":143,"completionDateStruct":145,"leadSponsor":147,"locationsCount":46},"100576701","mdr---comprehensive-primary-revision-stems-pmcf-100576701","NCT06788717","MDR - Comprehensive Primary Revision Stems PMCF","Post-market Clinical Follow-up Study to Provide Safety, Performance and Clinical Benefits Data of the Comprehensive® Primary Revision Stems (Implants and Instrumentation) - A Retrospective and Prospective Consecutive Series Study","Inclusion Criteria\n\n* Patient must be 18 years of age or older.\n* Patient must be willing and able to follow directions.\n* Study devices must have been implanted following the surgical technique and IFU for the Comprehensive Revision Stem\n\nExclusion Criteria\n\n* Off-label use.\n* Patient is a prisoner.\n* Patient is a current alcohol or drug abuser.\n* Patient has a psychiatric illness or cognitive deficit that will not allow for proper informed consent.\n* Patient is unwilling to sign informed consent.\n* Uncooperative patient or patient with neurologic disorders who are incapable of following directions.","100 Years",{"count":138,"type":20},59,"The objective of this retrospective and prospective consecutive series PMCF (Post Market Clinical Follow Up) study is to collect long-term data confirming safety, performance and clinical benefits of the Comprehensive Primary Revision Stems (implants and instrumentation) when used for shoulder arthroplasty at 1, 3, 5, 7 and 10 years.",[27,118,24,120,119],{"date":142,"type":38},"2026-04-28",{"date":144,"type":38},"2025-06-19",{"date":146,"type":20},"2040-12",{"name":44,"class":45},{"id":149,"slug":150,"hasResults":11,"nctId":151,"briefTitle":152,"officialTitle":14,"acronym":4,"eligibilityCriteria":153,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":154,"targetDuration":4,"studyType":156,"phases":157,"briefSummary":159,"conditions":160,"keywords":163,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":121,"lastUpdatePostDateStruct":175,"startDateStruct":176,"completionDateStruct":178,"leadSponsor":180,"locationsCount":181},"100438054","zimmer-biomet-shoulder-arthroplasty-pmcf-100438054","NCT04984291","Zimmer Biomet Shoulder Arthroplasty PMCF","Inclusion Criteria:\n\n* Patient must be 20 years of age or older.\n* Patient must be anatomically and structurally suited to receive shoulder arthroplasty implants.\n* Patient is a candidate for shoulder arthroplasty due to one or more of the following:\n\n  * Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis.\n  * Rheumatoid arthritis.\n  * Correction of functional deformity.\n  * Fractures of the proximal humerus, where other methods of treatment are deemed inadequate.\n  * Difficult clinical management problems, where other methods of treatment may not be suitable or may be inadequate.\n* Patient must be able and willing to complete the protocol required follow-up.\n* Patient must be able and willing to sign the IRB\u002FEC approved informed consent.\n* Patient has grossly deficient rotator, (for reverse application)\n\n  * With severe arthropathy and\u002For\n  * Previously failed shoulder joint replacement\n* Patient must have functional deltoid muscle (for reverse application)\n\nExclusion Criteria:\n\n* Patient is unwilling or unable to give consent or to comply with the follow-up program.\n* Patient has any condition which would in the judgement of the Investigator, place the patient at undue risk or interfere with the study.\n* Patient is known to be pregnant or breastfeeding.\n* Patient is a vulnerable subject (prisoner, mentally incompetent or unable to understand what participation to the study entails, a known alcohol or drug abuser, and\u002For anticipated to be non-compliant).\n* Patient is uncooperative or patient with neurologic disorders who is incapable or unwilling to follow directions.\n* Patient has any sign of infection affecting the shoulder joint or in its proximity which may spread to the implant site.\n* Patient has rapid joint destruction, marked bone loss, or bone resorption apparent on roentgenogram.\n* Patient has any neuromuscular disease compromising the affected limb that would render the procedure unjustifiable.\n* Patient presents with osteoporosis, which in the opinion of the Investigator, may limit the subject's ability to support total shoulder arthroplasty using the study device.\n* Patient has osteomalacia.\n* Patient has a metabolic disorder that may impair bone formation.\n* Patient has deficient rotator cuff.\n* Patient presents with significant injury to the upper brachial plexus.\n* Patient has paralysis of the axillary nerve.\n* Patient has non-functional deltoid or external rotator muscles.",{"count":155,"type":20},584,"INTERVENTIONAL",[158],"NA","The objectives of this study are to confirm the safety, performance, and clinical benefits of Zimmer Biomet Shoulder Arthroplasty Systems and its instrumentation in primary or revision shoulder arthroplasty. These objectives will be assessed using standard scoring systems, radiographic evidence, and adverse event records. Safety of the system will be assessed by monitoring the frequency an incidence of adverse events.",[24,119,161,162,118,27],"Shoulder Osteoarthritis","Shoulder Deformity",[164,165,166,167,168,169,170,171,172,173,174],"Total Shoulder Arthroplasty","Glenoid","Humeral Stem","Stem Adapter","Humeral Head","Humeral Bearing","Humeral Trays","Head Adapter","Reverse","Anatomic","Hemi",{"date":142,"type":38},{"date":177,"type":38},"2021-07-28",{"date":179,"type":20},"2033-08-15",{"name":44,"class":45},17,{"id":183,"slug":184,"hasResults":11,"nctId":185,"briefTitle":186,"officialTitle":187,"acronym":4,"eligibilityCriteria":188,"healthyVolunteers":11,"sex":16,"minAge":88,"maxAge":189,"enrollmentInfo":190,"targetDuration":4,"studyType":156,"phases":192,"briefSummary":193,"conditions":194,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":196,"lastUpdatePostDateStruct":197,"startDateStruct":199,"completionDateStruct":201,"leadSponsor":203,"locationsCount":79},"100543536","efficacy-of-early-multimodal-physiotherapy-in-patients-with-reverse-shoulder-prosthesis-100543536","NCT06357143","Efficacy of Early Multimodal Physiotherapy in Patients With Reverse Shoulder Prosthesis","Efficacy of Early Multimodal Physiotherapy in Patients With Reverse Shoulder Prosthesis: a Randomized Controlled Trial.","Inclusion Criteria:\n\n* Adults with a reverse shoulder prosthesis.\n* Age between 18 and 90 years.\n* Signed informed consent.\n\nExclusion Criteria:\n\n* Language or cultural barriers.\n* Other upper limb injury.\n* Treatment that affect physical activity capacity.","90 Years",{"count":191,"type":20},40,[158],"The present study try to evaluate the effectivenness of an early intervention program based on multimodal physiotherapy and focused on therapeutic exercise to improve the results of patients with a reverse shoulder phrostesis. This trial will be a randomized controlled trial with parallel groups, and outcomes variables will include psychometric properties through the use of specific questionnaries, and laboratory variables such as strength with a dynamometer, range of movement with a goniometer, muscle mass with an ultrasound, and kinematic parameters with inertial sensors. This study aims to develop an original intervention program in order to try to establish new protocols in the management of these patients.",[24,195],"Prosthesis User","2026-04-02",{"date":198,"type":38},"2026-04-08",{"date":200,"type":38},"2025-09-01",{"date":202,"type":20},"2027-12",{"name":204,"class":78},"University of Malaga",{"id":206,"slug":207,"hasResults":11,"nctId":208,"briefTitle":209,"officialTitle":210,"acronym":211,"eligibilityCriteria":212,"healthyVolunteers":11,"sex":16,"minAge":213,"maxAge":214,"enrollmentInfo":215,"targetDuration":4,"studyType":156,"phases":217,"briefSummary":218,"conditions":219,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":221,"lastUpdatePostDateStruct":222,"startDateStruct":224,"completionDateStruct":226,"leadSponsor":228,"locationsCount":46},"100548101","surgical-versus-non-surgical-treatment-of-displaced-proximal-humerus-fracture-in-adults-aged-50-to-65-years-100548101","NCT06416618","Surgical Versus Non-surgical Treatment of Displaced Proximal Humerus Fracture in Adults Aged 50 to 65 Years","Surgical Versus Non-surgical Treatment of Displaced Proximal Humerus Fracture in Adults Aged 50 to 65 Years: a Pragmatic Randomized Controlled Trial","PHF50-65","Inclusion Criteria:\n\n* Patients aged between 50 and 65 years with a displaced PHF assessed to be constructible by the treating surgeon after a low-energy trauma will be considered for eligibility.\n* Patients should be cognitively capable of answering the follow-up questionnaires.\n\nExclusion Criteria:\n\n* The patient does not understand written and spoken native language (Danish or Finnish\u002FSwedish)\n* Inability to give informed consent\n* Fractures assessed to be unreconstructedly by the treating surgeon\n* Isolated tuberosity fracture, fracture dislocations, open fractures, and fractures with involvement of the articular surface\n* Less than 25% contact between head fragment and metaphysis\u002Fdiaphysis measured at two perpendicular radiographs at two weeks.\n* Pathological fractures or previous fractures in the same proximal humerus\n* Concomitant fractures, which could influence the outcome\n* Paralysis in upper extremity","50 Years","65 Years",{"count":216,"type":20},60,[158],"The goal of this clinical trial is to study whether surgery results in better functional outcomes than non-surgical treatment among patients aged 50-65 with a displaced proximal humerus fracture.\n\nThe main questions it aims to answer are:\n\n• Does osteosynthesis result in better patient-reported functional outcomes compared to non-surgical treatment at 12 months follow-up?\n\nAim is also to characterize the patient group aged 50-65 regarding fracture morphology, osteoporosis, and clinical frailty scale.\n\nThe study compare operation with either plate or nail fixation to non-surgical treatment.\n\nParticipants will:\n\n* Receive either surgical treatment or non-surgical treatment.\n* At 6 months, 1 year, and 2 years, the patient will answer two short questionnaires (Oxford Shoulder Score and Eq-5D-3L).\n\nThe primary outcome will be Oxford Shoulder Score at 12 months. The secondary outcome will be OSS at 6 and 24 months and EQ-5D-3L score measured at the same time-points. Adverse events and conversion to surgery will be registered. OSS and EQ-5D-3L will be completed just before the 6 months visit.",[220,24],"Proximal Humeral Fracture","2025-09-11",{"date":223,"type":38},"2025-09-18",{"date":225,"type":38},"2024-05-15",{"date":227,"type":20},"2028-12-31",{"name":229,"class":78},"Zealand University Hospital",{"id":231,"slug":232,"hasResults":11,"nctId":233,"briefTitle":234,"officialTitle":235,"acronym":4,"eligibilityCriteria":236,"healthyVolunteers":11,"sex":16,"minAge":88,"maxAge":4,"enrollmentInfo":237,"targetDuration":239,"studyType":21,"phases":4,"briefSummary":240,"conditions":241,"keywords":4,"overallStatus":68,"whyStopped":4,"lastUpdateSubmitDate":242,"lastUpdatePostDateStruct":243,"startDateStruct":245,"completionDateStruct":247,"leadSponsor":249,"locationsCount":79},"100543824","management-of-proximal-humerus-fractures-in-adults-a-clinical-trial-100543824","NCT06360887","Management of Proximal Humerus Fractures in Adults: a Clinical Trial","Management of Proximal Humerus Fractures in Elderlies: a Clinical Trial","Inclusion Criteria:\n\n1. adults who sustained a Proximal Humerus Fracture within the last week\n2. type of Proximal Humerus Fracture AO 11-(A2, A3), 11- (B1, B2, B3)\n3. BMI lower than 40 Kg\u002Fm2\n\nExclusion Criteria:\n\n1. stress fractures\n2. revision setting\n3. open fractures\n4. fractures associated with a neurologic lesion; previous fractures or bony procedure at the homolateral side\n5. patients unable to understand the procedure or instructions for rehabilitation\n6. terminal patients\n7. patients presenting multiple injuries",{"count":238,"type":20},351,"2 Years","Prospective patient registry examining the outcome of three different treatment methods for proximal humerus fractures in elderlies: conservative treatment, open and minimal invasive surgical treatment.",[24],"2024-04-10",{"date":244,"type":38},"2024-04-12",{"date":246,"type":20},"2024-04",{"date":248,"type":20},"2028-01-31",{"name":250,"class":78},"Regional Hospital of Bolzano"]